ATE474552T1 - ßFESTE DOSIERUNGSFORM ZUR OKULAREN APPLIKATION EINER WIRKSUBSTANZ, LÖSLICHE, FESTE OPHTHALMISCHE EINLAGE SOWIE HERSTELLUNGSVERFAHREN DAFÜRß - Google Patents

ßFESTE DOSIERUNGSFORM ZUR OKULAREN APPLIKATION EINER WIRKSUBSTANZ, LÖSLICHE, FESTE OPHTHALMISCHE EINLAGE SOWIE HERSTELLUNGSVERFAHREN DAFÜRß

Info

Publication number
ATE474552T1
ATE474552T1 AT02804932T AT02804932T ATE474552T1 AT E474552 T1 ATE474552 T1 AT E474552T1 AT 02804932 T AT02804932 T AT 02804932T AT 02804932 T AT02804932 T AT 02804932T AT E474552 T1 ATE474552 T1 AT E474552T1
Authority
AT
Austria
Prior art keywords
solid
soluble
dosage form
production method
active substance
Prior art date
Application number
AT02804932T
Other languages
English (en)
Inventor
Meski Said El
Philippe Tourrette
Jean-Marc Aiache
Battista Marie Di
Gilbert Serpin
Original Assignee
Ioltechnologie Production
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8870629&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE474552(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ioltechnologie Production filed Critical Ioltechnologie Production
Application granted granted Critical
Publication of ATE474552T1 publication Critical patent/ATE474552T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02804932T 2001-12-18 2002-12-17 ßFESTE DOSIERUNGSFORM ZUR OKULAREN APPLIKATION EINER WIRKSUBSTANZ, LÖSLICHE, FESTE OPHTHALMISCHE EINLAGE SOWIE HERSTELLUNGSVERFAHREN DAFÜRß ATE474552T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0116377A FR2833493B1 (fr) 2001-12-18 2001-12-18 Forme galenique solide et soluble pour l'administration occulaire de principes actifs et procede de fabrication d'un insert ophtalmique solide et soluble
PCT/FR2002/004384 WO2003051330A1 (fr) 2001-12-18 2002-12-17 Forme galenique solide pour l'administration oculaire de principe actif, insert ophtalmique solide et soluble et procede de fabrication d'un tel insert

Publications (1)

Publication Number Publication Date
ATE474552T1 true ATE474552T1 (de) 2010-08-15

Family

ID=8870629

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02804932T ATE474552T1 (de) 2001-12-18 2002-12-17 ßFESTE DOSIERUNGSFORM ZUR OKULAREN APPLIKATION EINER WIRKSUBSTANZ, LÖSLICHE, FESTE OPHTHALMISCHE EINLAGE SOWIE HERSTELLUNGSVERFAHREN DAFÜRß

Country Status (12)

Country Link
US (1) US8663678B2 (de)
EP (1) EP1465594B1 (de)
JP (1) JP4917738B2 (de)
CN (1) CN1615120B (de)
AT (1) ATE474552T1 (de)
AU (1) AU2002364658A1 (de)
CA (1) CA2470377C (de)
DE (1) DE60237111D1 (de)
ES (1) ES2349295T3 (de)
FR (1) FR2833493B1 (de)
PT (1) PT1465594E (de)
WO (1) WO2003051330A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007013590A1 (ja) * 2005-07-29 2007-02-01 Santen Pharmaceutical Co., Ltd. 固形組成物を用いた後眼部組織への非侵襲性ドラッグデリバリーシステム
US9877973B2 (en) * 2008-05-12 2018-01-30 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
AU2014329412B2 (en) * 2013-10-03 2020-02-27 Harrow Ip, Llc Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
CZ2014451A3 (cs) 2014-06-30 2016-01-13 Contipro Pharma A.S. Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití
CZ309295B6 (cs) 2015-03-09 2022-08-10 Contipro A.S. Samonosný, biodegradabilní film na bázi hydrofobizované kyseliny hyaluronové, způsob jeho přípravy a použití
CZ306479B6 (cs) 2015-06-15 2017-02-08 Contipro A.S. Způsob síťování polysacharidů s využitím fotolabilních chránicích skupin
CZ306662B6 (cs) 2015-06-26 2017-04-26 Contipro A.S. Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití
EP3108874A1 (de) * 2015-06-26 2016-12-28 TRB Chemedica AG Pharmazeutische zubereitung zur anwendung am auge
CZ308106B6 (cs) 2016-06-27 2020-01-08 Contipro A.S. Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití
CN106074361B (zh) * 2016-07-14 2018-10-19 何伟 一种抗眼内炎症植入剂及其制备方法和应用
EP4138745A4 (de) * 2020-04-20 2024-05-29 Avisi Ltd. Ophthalmische vorrichtung

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993071A (en) * 1971-09-09 1976-11-23 Alza Corporation Bioerodible ocular device
US4179497A (en) * 1973-12-17 1979-12-18 Merck & Co., Inc. Solid state ophthalmic medication
NL188266C (nl) * 1975-07-29 1992-05-18 Merck & Co Inc Werkwijze ter bereiding van een oogheelkundig inplantaat.
US4518433A (en) * 1982-11-08 1985-05-21 Fmc Corporation Enteric coating for pharmaceutical dosage forms
IT1223150B (it) * 1987-11-18 1990-09-12 Ubaldo Conte Compressa per uso oftalmico e rilascio controllato della sostanza attiva
IE920040A1 (en) * 1991-01-09 1992-07-15 Alza Corp Bioerodible devices and compositions for diffusional release¹of agents
FR2688694B1 (fr) * 1992-03-20 1999-06-25 Vetoquinol Sa Insert ophtalmique bioadhesif.
AU5092493A (en) * 1992-09-08 1994-03-29 Allergan, Inc. Sustained release of ophthalmic drugs from a soluble polymer drug delivery vehicle
US5443505A (en) * 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
JPH08127533A (ja) * 1994-11-01 1996-05-21 Taisho Pharmaceut Co Ltd 内服固形製剤用組成物
EP0903151A1 (de) * 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Verwendung von Kombinationen enthaltend nichtsedierende Antihistaminika und Alfa-Adrenergische Agonisten für die topische Behandlung von Rhinitis/Konjunktivitis sowie Erkältungs- und Grippe-Symptomen
SE9802973D0 (sv) * 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
JP4828678B2 (ja) * 1998-11-18 2011-11-30 武田薬品工業株式会社 圧縮成形物
JP2001081048A (ja) * 1999-09-10 2001-03-27 Wakamoto Pharmaceut Co Ltd 眼圧降下剤
JP3435664B2 (ja) * 1999-12-08 2003-08-11 ヤンセンファーマ株式会社 口腔内速崩壊型錠剤及びその製造方法
US6548535B2 (en) * 2000-01-18 2003-04-15 Merck & Co., Inc. Method for treating ocular hypertension
DE10007203A1 (de) * 2000-02-17 2001-08-23 Asta Medica Ag Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis

Also Published As

Publication number Publication date
WO2003051330A1 (fr) 2003-06-26
ES2349295T3 (es) 2010-12-29
US8663678B2 (en) 2014-03-04
CA2470377A1 (fr) 2003-06-26
US20050118231A1 (en) 2005-06-02
EP1465594B1 (de) 2010-07-21
CN1615120A (zh) 2005-05-11
CA2470377C (fr) 2013-09-17
PT1465594E (pt) 2010-10-27
JP4917738B2 (ja) 2012-04-18
FR2833493A1 (fr) 2003-06-20
EP1465594A1 (de) 2004-10-13
FR2833493B1 (fr) 2005-09-23
CN1615120B (zh) 2012-09-19
DE60237111D1 (de) 2010-09-02
JP2005516922A (ja) 2005-06-09
AU2002364658A1 (en) 2003-06-30

Similar Documents

Publication Publication Date Title
WO2003002243A3 (en) Method and device for electrochemical formation of therapeutic species in vivo
WO2006017470A3 (en) Device and method for treating a vessel
PL362803A1 (en) Novel method and compositions for local treatment of meniere's disease, tinnitus and/or hearing loss
DE60237111D1 (de) "feste dosierungsform zur okularen applikation einer wirksubstanz, lösliche, feste ophthalmische einlage sowie herstellungsverfahren dafür"
BR9503386A (pt) Formulaçao farmacêutica comprimido dispersivel e processo para a fabricaçao de comprimidos dispersíveis contendo cloridrato de fluoxetina
WO2004078025A3 (en) Vascular assist device and methods
AU2002338483A1 (en) Drainage implant for draining aqueous humour from the anterior aqueous chamber of the eye into schlemm's canal
MY132831A (en) Method and device to improve aqueous humor drainage in an eye
WO2002096318A3 (en) Method for treating glaucoma v
IS5946A (is) Aðferð til að búa til agnir þar sem myndlausu og/eða hálfstöðugu svæði hefur verið umbreytt á kristallaform
WO2007065619A3 (de) Schaumwafer mit polyvinylalkohol-polyethylenglycol-pfropfcopolymer
CA2454976A1 (en) Therapeutic agent for glaucoma comprising compound having pi3 kinase inhibitory action as active ingredient
MX2009013062A (es) Derivados de 3´4´,5-trimetoxi flavona como estimulante de secrecion de mucosa, metodo de los mismos, y composicion farmaceutica que comprende los mismos.
WO2003094905A8 (en) Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders
HUP0101177A2 (hu) Glikogén alkalmazása mesterséges könnyként felhasználható oldat előállítására
MXPA03010363A (es) Metodo para tratar hipertension ocular y glaucoma.
CO5280202A1 (es) Metodos de tratamiento y metodos de rastreo de farmacos
WO2001054707A3 (de) Veränderung von oberflächenproteomem durch aminopeptidase-inhibitoren
BR0316123A (pt) Formulação farmacêutica aquosa, uso de uma formulação farmacêutica aquosa, e, método de tratamento de um paciente com necessidade de tratamento antitrombótico
RU2000119720A (ru) Способ предотвращения дислокации силикона в переднюю камеру при хирургическом лечении рецидивирующих отслоек сетчатки
PT1067907E (pt) Solucao para irrigacao ocular
RU2000104106A (ru) Способ устранения иридодиализа
RU97116792A (ru) Способ лечения эрозий роговицы после эксимерлазерной фоторефракционной кератэктомии
RU2002125733A (ru) Способ лечения дистрофии роговицы
WO2002064108A3 (en) Delivery of biologically active agents

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties